In the face of complexity, confidence matters. Not only for patient compliance, but also when selecting a CDMO to develop and manufacture highly complex formulations like fixed-dose combination (FDC) products.
Halo Pharmaceutical specializes and has extensive experience in the development and manufacture of FDCs. These products can be a great option to:
We have developed more than a half dozen multi-API mini-tablets, bilayer tablets, and multi-API coated tablets in both IR and ER formulations. Download our case study
Halo Pharma possesses state-of-the-art equipment and know-how to help you bring these complex combination products to market. Download our white paper
You can be confident that Halo Pharma will be a trusted partner in developing and manufacturing your fixed-dose combination product – ultimately supporting you in getting to market in a timely, cost-effective manner.